This paper initially reviews ligand and receptor systems for the PDGF
family and the signalling systems they use as well as their role in ne
ural developments. It then describes the putative role of this family
in astrocytoma, meningioma, and pituitary adenoma pathogenesis. Potent
ial therapies with receptor antagonists or dominant negative mutants a
re discussed in the final sections.